Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Extended Dosing Regimens for Fungal Prophylaxis.

Lehrnbecher T, Bochennek K, Klingebiel T, Gastine S, Hempel G, Groll AH.

Clin Microbiol Rev. 2019 May 15;32(3). pii: e00010-19. doi: 10.1128/CMR.00010-19. Print 2019 Jun 19. Review.

PMID:
31092507
2.

Brainstem biopsy in pediatric diffuse intrinsic pontine glioma in the era of precision medicine: the INFORM study experience.

Pfaff E, El Damaty A, Balasubramanian GP, Blattner-Johnson M, Worst BC, Stark S, Witt H, Pajtler KW, van Tilburg CM, Witt R, Milde T, Jakobs M, Fiesel P, Frühwald MC, Hernáiz Driever P, Thomale UW, Schuhmann MU, Metzler M, Bochennek K, Simon T, Dürken M, Karremann M, Knirsch S, Ebinger M, von Bueren AO, Pietsch T, Herold-Mende C, Reuss DE, Kiening K, Lichter P, Eggert A, Kramm CM, Pfister SM, Jones DTW, Bächli H, Witt O.

Eur J Cancer. 2019 Jun;114:27-35. doi: 10.1016/j.ejca.2019.03.019. Epub 2019 Apr 22.

PMID:
31022591
3.

Pontine tumor in a neonate: case report and analysis of the current literature.

Buus-Gehrig C, Lehrnbecher T, Porto L, Becker M, Freiman T, Mittelbronn M, Bochennek K.

J Neurosurg Pediatr. 2019 Feb 15:1-7. doi: 10.3171/2018.10.PEDS18215. [Epub ahead of print]

PMID:
30771760
4.

An Exponential Regression Model Reveals the Continuous Development of B Cell Subpopulations Used as Reference Values in Children.

Königs C, Schultze-Strasser S, Quaiser A, Bochennek K, Schwabe D, Klingebiel TE, Koehl U, Cappel C, Rolle U, Bader P, Bremm M, Huenecke S, Bakhtiar S.

Front Pediatr. 2018 May 4;6:121. doi: 10.3389/fped.2018.00121. eCollection 2018.

5.

Diagnostic Approaches for Invasive Aspergillosis-Specific Considerations in the Pediatric Population.

Lehrnbecher T, Hassler A, Groll AH, Bochennek K.

Front Microbiol. 2018 Mar 26;9:518. doi: 10.3389/fmicb.2018.00518. eCollection 2018. Review.

6.

Crizotinib in ALK+ inflammatory myofibroblastic tumors-Current experience and future perspectives.

Theilen TM, Soerensen J, Bochennek K, Becker M, Schwabe D, Rolle U, Klingebiel T, Lehrnbecher T.

Pediatr Blood Cancer. 2018 Apr;65(4). doi: 10.1002/pbc.26920. Epub 2017 Dec 29. Review.

PMID:
29286567
7.

Radical Surgery Improves Survival in Patients with Stage 4 Neuroblastoma.

Vollmer K, Gfroerer S, Theilen TM, Bochennek K, Klingebiel T, Rolle U, Fiegel H.

World J Surg. 2018 Jun;42(6):1877-1884. doi: 10.1007/s00268-017-4340-9.

PMID:
29127465
8.

First experience of the AML-Berlin-Frankfurt-Münster group in pediatric patients with standard-risk acute promyelocytic leukemia treated with arsenic trioxide and all-trans retinoid acid.

Creutzig U, Dworzak MN, Bochennek K, Faber J, Flotho C, Graf N, Kontny U, Rossig C, Schmid I, von Stackelberg A, Mueller JE, von Neuhoff C, Reinhardt D, von Neuhoff N.

Pediatr Blood Cancer. 2017 Aug;64(8). doi: 10.1002/pbc.26461. Epub 2017 Jan 23.

PMID:
28111878
9.

Role of natural killer cells in antibacterial immunity.

Schmidt S, Ullrich E, Bochennek K, Zimmermann SY, Lehrnbecher T.

Expert Rev Hematol. 2016 Dec;9(12):1119-1127. Epub 2016 Nov 11. Review.

PMID:
27791439
10.

Percentiles of Lymphocyte Subsets in Preterm Infants According to Gestational Age Compared to Children and Adolescents.

Huenecke S, Fryns E, Wittekindt B, Buxmann H, Königs C, Quaiser A, Fischer D, Bremm M, Klingebiel T, Koehl U, Schloesser R, Bochennek K.

Scand J Immunol. 2016 Nov;84(5):291-298. doi: 10.1111/sji.12474.

11.

Lack of Effectiveness of Neutropenic Diet and Social Restrictions as Anti-Infective Measures in Children With Acute Myeloid Leukemia: An Analysis of the AML-BFM 2004 Trial.

Tramsen L, Salzmann-Manrique E, Bochennek K, Klingebiel T, Reinhardt D, Creutzig U, Sung L, Lehrnbecher T.

J Clin Oncol. 2016 Aug 10;34(23):2776-83. doi: 10.1200/JCO.2016.66.7881. Epub 2016 Jun 6.

12.

Infectious Complications in Children With Acute Myeloid Leukemia and Down Syndrome: Analysis of the Prospective Multicenter Trial AML-BFM 2004.

Hassler A, Bochennek K, Gilfert J, Perner C, Schöning S, Creutzig U, Reinhardt D, Lehrnbecher T.

Pediatr Blood Cancer. 2016 Jun;63(6):1070-4. doi: 10.1002/pbc.25917. Epub 2016 Jan 27.

PMID:
26814618
13.

Infectious complications in children with acute myeloid leukemia: decreased mortality in multicenter trial AML-BFM 2004.

Bochennek K, Hassler A, Perner C, Gilfert J, Schöning S, Klingebiel T, Reinhardt D, Creutzig U, Lehrnbecher T.

Blood Cancer J. 2016 Jan 15;6:e382. doi: 10.1038/bcj.2015.110.

14.

Immune cell subsets at birth may help to predict risk of late-onset sepsis and necrotizing enterocolitis in preterm infants.

Bochennek K, Fryns E, Wittekindt B, Buxmann H, Quaiser A, Fischer D, Klingebiel T, Koehl U, Schloesser R, Huenecke S.

Early Hum Dev. 2016 Feb;93:9-16. doi: 10.1016/j.earlhumdev.2015.10.018. Epub 2015 Dec 17.

PMID:
26704574
15.

β-D-Glucan Screening for Detection of Invasive Fungal Disease in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.

Koltze A, Rath P, Schöning S, Steinmann J, Wichelhaus TA, Bader P, Bochennek K, Lehrnbecher T.

J Clin Microbiol. 2015 Aug;53(8):2605-10. doi: 10.1128/JCM.00747-15. Epub 2015 Jun 3.

16.

Micafungin twice weekly as antifungal prophylaxis in paediatric patients at high risk for invasive fungal disease.

Bochennek K, Balan A, Müller-Scholden L, Becker M, Farowski F, Müller C, Groll AH, Lehrnbecher T.

J Antimicrob Chemother. 2015 May;70(5):1527-30. doi: 10.1093/jac/dku544. Epub 2015 Jan 5.

PMID:
25564562
17.

Differential loss of humoral immunity against measles, mumps, rubella and varicella-zoster virus in children treated for cancer.

Bochennek K, Allwinn R, Langer R, Becker M, Keppler OT, Klingebiel T, Lehrnbecher T.

Vaccine. 2014 Jun 5;32(27):3357-61. doi: 10.1016/j.vaccine.2014.04.042. Epub 2014 Apr 29.

PMID:
24793952
18.

Response of children with stage IV soft tissue sarcoma to topotecan and carboplatin: a phase II window trial of the cooperative soft tissue sarcoma group.

Bochennek K, Dantonello T, Koscielniak E, Claviez A, Dirksen U, Sauerbrey A, Beilken A, Klingebiel T.

Klin Padiatr. 2013 Nov;225(6):309-14. doi: 10.1055/s-0033-1341489. Epub 2013 Aug 14.

PMID:
23946091
19.

Invasive aspergillosis in children and adolescents.

Groll AH, Schrey D, Tragiannidis A, Bochennek K, Lehrnbecher T.

Curr Pharm Des. 2013;19(20):3545-68. Review.

PMID:
23278537
20.

Impact of minimal residual disease detection prior to autologous stem cell transplantation for post-transplant outcome in high risk neuroblastoma.

Bochennek K, Esser R, Lehrnbecher T, Glienke W, Wehner S, Erben S, Soerensen J, Schwabe D, Bader P, Klingebiel T, Koehl U.

Klin Padiatr. 2012 Apr;224(3):139-42. doi: 10.1055/s-0031-1301334. Epub 2012 Feb 29.

PMID:
22377741
21.

Detection of neuroblastoma cells during clinical follow up: advanced flow cytometry and rt-PCR for tyrosine hydroxylase using both conventional and real-time PCR.

Esser R, Glienke W, Bochennek K, Erben S, Quaiser A, Pieper C, Eggert A, Schramm A, Astrahantseff K, Hansmann ML, Schwabe D, Klingebiel T, Koehl U.

Klin Padiatr. 2011 Nov;223(6):326-31. doi: 10.1055/s-0031-1287842. Epub 2011 Nov 17.

PMID:
22095188
22.

Liposomal amphotericin B twice weekly as antifungal prophylaxis in paediatric haematological malignancy patients.

Bochennek K, Tramsen L, Schedler N, Becker M, Klingebiel T, Groll AH, Lehrnbecher T.

Clin Microbiol Infect. 2011 Dec;17(12):1868-74. doi: 10.1111/j.1469-0691.2011.03483.x. Epub 2011 Sep 6.

23.

Immunotherapy against invasive fungal diseases in stem cell transplant recipients.

Lehrnbecher T, Tramsen L, Koehl U, Schmidt S, Bochennek K, Klingebiel T.

Immunol Invest. 2011;40(7-8):839-52. doi: 10.3109/08820139.2011.581732. Epub 2011 May 31.

PMID:
21627412
24.

The novel chimeric anti-NCAM (neural cell adhesion molecule) antibody ch.MK1 displays antitumor activity in SCID mice but does not activate complement-dependent cytolysis (CDC).

Klehr M, Koehl U, Mühlenhoff M, Tawadros S, Fischer T, Schomäcker K, Heuckmann JM, Bochennek K, Jensen M.

J Immunother. 2009 Jun;32(5):442-51. doi: 10.1097/CJI.0b013e31819f8b69.

PMID:
19609236
25.

Changes in host defence induced by malignancies and antineoplastic treatment: implication for immunotherapeutic strategies.

Lehrnbecher T, Koehl U, Wittekindt B, Bochennek K, Tramsen L, Klingebiel T, Chanock SJ.

Lancet Oncol. 2008 Mar;9(3):269-78. doi: 10.1016/S1470-2045(08)70071-8. Review.

PMID:
18308252
26.

Age-matched lymphocyte subpopulation reference values in childhood and adolescence: application of exponential regression analysis.

Huenecke S, Behl M, Fadler C, Zimmermann SY, Bochennek K, Tramsen L, Esser R, Klarmann D, Kamper M, Sattler A, von Laer D, Klingebiel T, Lehrnbecher T, Koehl U.

Eur J Haematol. 2008 Jun;80(6):532-9. doi: 10.1111/j.1600-0609.2008.01052.x. Epub 2008 Feb 12.

PMID:
18284628
27.

ISHAGE-based single-platform flowcytometric analysis for measurement of absolute viable T cells in fresh or cryopreserved products: CD34/CD133 selected or CD3/CD19 depleted stem cells, DLI and purified CD56+CD3- NK cells.

Koehl U, Bochennek K, Esser R, Brinkmann A, Quaritsch R, Becker M, Soerensen J, Bader P, Schwabe D, Klingebiel T, Fischer J, Zimmermann SY.

Int J Hematol. 2008 Jan;87(1):98-105. doi: 10.1007/s12185-007-0018-7. Epub 2007 Dec 18.

PMID:
18224422
28.

More than mere games: a review of card and board games for medical education.

Bochennek K, Wittekindt B, Zimmermann SY, Klingebiel T.

Med Teach. 2007 Nov;29(9):941-8. Review.

PMID:
18158669
29.

A novel five-colour flow cytometric assay to determine NK cell cytotoxicity against neuroblastoma and other adherent tumour cells.

Klöss S, Bochennek K, Huenecke S, Zimmermann SY, Kuçi S, Müller T, Wels WS, Klingebiel T, Esser R, Koehl U.

J Immunol Methods. 2007 Aug 31;325(1-2):140-7. Epub 2007 Jul 16.

PMID:
17663991
30.

Immune recovery in children undergoing allogeneic stem cell transplantation: absolute CD8+ CD3+ count reconstitution is associated with survival.

Koehl U, Bochennek K, Zimmermann SY, Lehrnbecher T, Sörensen J, Esser R, Andreas C, Kramm C, Grüttner HP, Falkenberg E, Orth A, Bader P, Schwabe D, Klingebiel T.

Bone Marrow Transplant. 2007 Mar;39(5):269-78.

PMID:
17311085
31.

Diagnostic approaches for immunocompromised paediatric patients with pulmonary infiltrates.

Bochennek K, Abolmaali N, Wittekindt B, Schwabe D, Klingebiel T, Lehrnbecher T.

Clin Microbiol Infect. 2006 Mar;12(3):199-201. Review.

32.

Hourly monitoring of circulating CD34+ cells to optimize timing of autologous apheresis in pediatric patients.

Bochennek K, Andreas C, Margraf C, Stahlkamp H, Zimmermann S, Esser R, Schwabe D, Klingebiel T, Grüttner HP, Koehl U.

Bone Marrow Transplant. 2005 Sep;36(6):481-9.

PMID:
16044142

Supplemental Content

Loading ...
Support Center